ShanXi C&Y Pharmaceutical Group Co.,LTD.

SZSE:300254 Stock Report

Market Cap: CN¥2.0b

ShanXi C&Y Pharmaceutical GroupLTD Balance Sheet Health

Financial Health criteria checks 4/6

ShanXi C&Y Pharmaceutical GroupLTD has a total shareholder equity of CN¥803.4M and total debt of CN¥230.4M, which brings its debt-to-equity ratio to 28.7%. Its total assets and total liabilities are CN¥1.5B and CN¥672.9M respectively. ShanXi C&Y Pharmaceutical GroupLTD's EBIT is CN¥37.8M making its interest coverage ratio 1.7. It has cash and short-term investments of CN¥131.9M.

Key information

28.7%

Debt to equity ratio

CN¥230.38m

Debt

Interest coverage ratio1.7x
CashCN¥131.92m
EquityCN¥803.38m
Total liabilitiesCN¥672.86m
Total assetsCN¥1.48b

Recent financial health updates

No updates

Recent updates

ShanXi C&Y Pharmaceutical Group Co.,LTD.'s (SZSE:300254) 36% Price Boost Is Out Of Tune With Revenues

May 27
ShanXi C&Y Pharmaceutical Group Co.,LTD.'s (SZSE:300254) 36% Price Boost Is Out Of Tune With Revenues

ShanXi C&Y Pharmaceutical Group (SZSE:300254) Strong Profits May Be Masking Some Underlying Issues

Mar 25
ShanXi C&Y Pharmaceutical Group (SZSE:300254) Strong Profits May Be Masking Some Underlying Issues

ShanXi C&Y Pharmaceutical Group Co., Ltd.'s (SZSE:300254) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Mar 06
ShanXi C&Y Pharmaceutical Group Co., Ltd.'s (SZSE:300254) Price Is Right But Growth Is Lacking After Shares Rocket 28%

Financial Position Analysis

Short Term Liabilities: 300254's short term assets (CN¥417.3M) do not cover its short term liabilities (CN¥447.2M).

Long Term Liabilities: 300254's short term assets (CN¥417.3M) exceed its long term liabilities (CN¥225.6M).


Debt to Equity History and Analysis

Debt Level: 300254's net debt to equity ratio (12.3%) is considered satisfactory.

Reducing Debt: 300254's debt to equity ratio has reduced from 29.4% to 28.7% over the past 5 years.

Debt Coverage: 300254's debt is well covered by operating cash flow (34.7%).

Interest Coverage: 300254's interest payments on its debt are not well covered by EBIT (1.7x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.